chr14-95116698-G-GA

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2

The NM_177438.3(DICER1):​c.1510-4dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00143 in 1,529,938 control chromosomes in the GnomAD database, including 6 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0038 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 6 hom. )

Consequence

DICER1
NM_177438.3 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.900

Publications

1 publications found
Variant links:
Genes affected
DICER1 (HGNC:17098): (dicer 1, ribonuclease III) This gene encodes a protein possessing an RNA helicase motif containing a DEXH box in its amino terminus and an RNA motif in the carboxy terminus. The encoded protein functions as a ribonuclease and is required by the RNA interference and small temporal RNA (stRNA) pathways to produce the active small RNA component that represses gene expression. This protein also acts as a strong antiviral agent with activity against RNA viruses, including the Zika and SARS-CoV-2 viruses. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2021]
DICER1 Gene-Disease associations (from GenCC):
  • DICER1-related tumor predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • pleuropulmonary blastoma
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • DICER1 syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 14-95116698-G-GA is Benign according to our data. Variant chr14-95116698-G-GA is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 220593.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00381 (559/146646) while in subpopulation AFR AF = 0.0126 (504/39994). AF 95% confidence interval is 0.0117. There are 0 homozygotes in GnomAd4. There are 274 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 559 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DICER1NM_177438.3 linkc.1510-4dupT splice_region_variant, intron_variant Intron 9 of 26 ENST00000343455.8 NP_803187.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DICER1ENST00000343455.8 linkc.1510-4_1510-3insT splice_region_variant, intron_variant Intron 9 of 26 1 NM_177438.3 ENSP00000343745.3

Frequencies

GnomAD3 genomes
AF:
0.00377
AC:
553
AN:
146558
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0125
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00149
Gnomad ASJ
AF:
0.000293
Gnomad EAS
AF:
0.00118
Gnomad SAS
AF:
0.00130
Gnomad FIN
AF:
0.000436
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000211
Gnomad OTH
AF:
0.00149
GnomAD2 exomes
AF:
0.00203
AC:
432
AN:
213306
AF XY:
0.00175
show subpopulations
Gnomad AFR exome
AF:
0.0130
Gnomad AMR exome
AF:
0.00145
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.00279
Gnomad FIN exome
AF:
0.00112
Gnomad NFE exome
AF:
0.00107
Gnomad OTH exome
AF:
0.00161
GnomAD4 exome
AF:
0.00117
AC:
1622
AN:
1383292
Hom.:
6
Cov.:
32
AF XY:
0.00106
AC XY:
728
AN XY:
689448
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0138
AC:
431
AN:
31250
American (AMR)
AF:
0.00144
AC:
60
AN:
41728
Ashkenazi Jewish (ASJ)
AF:
0.000525
AC:
13
AN:
24740
East Asian (EAS)
AF:
0.00128
AC:
49
AN:
38140
South Asian (SAS)
AF:
0.000894
AC:
74
AN:
82732
European-Finnish (FIN)
AF:
0.00119
AC:
60
AN:
50468
Middle Eastern (MID)
AF:
0.00127
AC:
7
AN:
5510
European-Non Finnish (NFE)
AF:
0.000740
AC:
778
AN:
1051674
Other (OTH)
AF:
0.00263
AC:
150
AN:
57050
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.346
Heterozygous variant carriers
0
136
272
409
545
681
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00381
AC:
559
AN:
146646
Hom.:
0
Cov.:
32
AF XY:
0.00385
AC XY:
274
AN XY:
71184
show subpopulations
African (AFR)
AF:
0.0126
AC:
504
AN:
39994
American (AMR)
AF:
0.00142
AC:
21
AN:
14744
Ashkenazi Jewish (ASJ)
AF:
0.000293
AC:
1
AN:
3410
East Asian (EAS)
AF:
0.00118
AC:
6
AN:
5088
South Asian (SAS)
AF:
0.00130
AC:
6
AN:
4616
European-Finnish (FIN)
AF:
0.000436
AC:
4
AN:
9174
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
286
European-Non Finnish (NFE)
AF:
0.000211
AC:
14
AN:
66400
Other (OTH)
AF:
0.00148
AC:
3
AN:
2032
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
27
54
80
107
134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00502
Hom.:
0

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Aug 18, 2021
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:2
Oct 08, 2021
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Sep 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DICER1: BP4, BS1, BS2

Hereditary cancer-predisposing syndrome Benign:2
Jun 01, 2016
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

Sep 10, 2020
Sema4, Sema4
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

Euthyroid goiter;C1266144:Pleuropulmonary blastoma;C1867234:Rhabdomyosarcoma, embryonal, 2;C4748924:Global developmental delay - lung cysts - overgrowth - Wilms tumor syndrome Benign:1
Jun 13, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Pleuropulmonary blastoma Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DICER1-related tumor predisposition Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.90
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs546524688; hg19: chr14-95583035; COSMIC: COSV104413821; API